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Effect of Dietary Substitution of Groundnut Oil
on Blood Glucose, Lipid Profile, and Redox
Status in Streptozotocin-diabetic Rats
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The effect of groundnut oil on blood glucose, lipid profile, lipid peroxidation, and antioxidant
status in streptozotocin-diabetic rats was investigated and compared with diabetic and drug-
treated rats. Diabetes was induced in adult female Wistar rats by intraperitoneal administra-
tion of streptozotocin (40 mg/kg b-wt). Normal and diabetic rats were fed an oil-free diet
containing 2 percent oil supplemented with groundnut oil (6g per 94g diet), to give 8 percent
oil content, for 42 days. Diabetic rats had elevated levels of glucose (322.61 + 9.49), gly-
cosylated hemoglobin (HbA1c)†, vitamin E, thiobarbituric acid reactive substances (TBARS),
and lipid hydroperoxides (HP) and decreased levels of hemoglobin (Hb), vitamin C and re-
duced glutathione (GSH). An increase in the activities of glucose-6-phosphatase and fruc-
tose-1,6-bisphosphatase and a decrease in hexokinase activity also were observed in the
liver and kidney. When diabetic rats were fed groundnut oil, a significant reduction in glucose
(244.04 + 11.66), HbA1c, TBARS, HP levels, glucose-6-phosphatase, and fructose-1,6-
bisphosphatase activities and an elevation in Hb, vitamin E, GSH levels, and hexokinase ac-
tivity were observed. Diabetic rats had elevated total cholesterol (TC), VLDL-cholesterol,
LDL-cholesterol, and triglycerides (TG) and decreased HDL-cholesterol. Diabetic rats fed
groundnut oil showed a small but significant reduction in TC, VLDL-C, LDL-C, and TG and
an elevation in HDL-C. Groundnut oil consumption slightly but significantly decreases the
blood glucose, HbA1c, lipid peroxidation, and lipid profile and increases antioxidant levels in
diabetic rats.
Currently, there are 150 million diabet-
ics worldwide, and this number is likely to
increase to 300 million or more by the year
2025 due to increases in sedentary life-
styles, consumption of energy-rich diets
and obesity [1,2]. While the management
of diabetes mellitus includes diet, exercise,
oral hypoglycemic agents, and insulin,
these do not effectively prevent the compli-
cations of diabetes mellitus [3]. In modern
medicine, there is still no satisfactory effec-
tive therapy available to cure diabetes [4].
Therefore, it has become necessary to
search for an economically and therapeuti-
cally effective treatment, especially for
usage in developing and under-developed
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countries. Many indigenous medicinal
plants have been found to be useful to suc-
cessfully manage diabetes [5].
Groundnut oil is widely used in south
India for cooking. Groundnut oil contains 46
and 32 percent of monounsaturated fatty
acids (MUFA) and polyunsaturated fatty
acids (PUFA), respectively [6]. Rasmussen
et al. noted a reduction in peak plasma glu-
cose concentration with the consumption of
a monounsaturated fatty acid-rich diet [7].
Reportsareavailableontheeffectofground-
nut oil on normal and high-fat diets [8] and
myocardial infarction [9]. No investigation
has been carried out to study the effect of
groundnutoilonglycemiccontrolindiabetic
rats. Since groundnut oil contains46 percent
of MUFA, we were interested in exploring
the role of groundnut oil in diabetes.
In diabetes, hyperglycemia results in
the generation of free radicals [10] due to
autoxidation of glucose [11] and glycosyla-
tion of proteins [12]. Free radicals react with
lipids and cause peroxidative changes that
result in enhanced lipid peroxidation [13].
The level of lipid peroxidation in cells is
controlled by various cellular defense mech-
anisms consisting of enzymatic and nonen-
zymatic scavenging systems [14]. The
efficiency of the antioxidant defense mech-
anism is altered in diabetes [15]. Hence, in
this study, we investigate the effect of
groundnut oil on blood glucose, carbohy-
drate metabolic enzymes, lipid profile, lipid
peroxidation, and nonenzymatic antioxi-
dants in normal and STZ-diabetic rats.
MATERIALS AND METHODS
Oil and treatment diet
Standard pellet diet and oil-free diet
were purchased from PranavAgro Industries
Ltd., Pune, India. Groundnut oil (SVS
groundnut oil, trade name) was purchased
from the local market. The oil was stored in
a jar at 4 oC. The standard pellet diet con-
tained 8 percent oil. Since the oil-free diet
contained 2 percent oil, 94 g of this diet was
mixed with 6 g of groundnut oil to make an
8 percent oil content.
Chemicals
Streptozotocin was procured from
Sigma-Aldrich, St. Louis, United States, and
glibenclamide from Hoechts, Frankfurt,
Germany. All other chemicals used were of
analytical grade and obtained from E.
Merck, Darmstadt, Germany, and Hi-media,
India.
Experimental animals
Adult albino female Wistar rats with
body weight of 180 to 200 g bred in Central
Animal House, Department of Experimental
Medicine, Rajah Muthiah Medical College,
Annamalai University, were used in this
study. The feed and water were provided ad
libitum to the animals.
Experimental induction of diabetes
The animals were made diabetic with
an intraperitoneal injection of STZ at a dose
of 40 mg/kg b-wt dissolved in citrate buffer
(0.1 M, pH 4.5). STZ-injected animals ex-
hibited massive glycosuria and hyper-
glycemia within a few days. Diabetes was
confirmed in the overnight-fasted rats by
measuring blood glucose concentration 96
hr after injection with STZ. The rats with
blood glucose above 240 mg/dl were con-
sidered to be diabetic and used for the ex-
periment.
Experimental design
The animals were randomly divided
into five groups of six animals each.
Group I: Normal
Group II: Normal + groundnut oil diet
Group III: Diabetic control
Group IV: Diabetic + groundnut oil diet
Group V: Diabetic + glibenclamide (600 ﾵg/kg
b-wt)
After 42 days of treatment, the 12 hr-
fasted animals were sacrificed by cervical
decapitation between 8 a.m. and 9 a.m.
Blood was collected in tubes containing a
mixture of potassium oxalate and sodiumTable 1. Effect of groundnut oil in diet on blood glucose and body weight in normal
and diabetic animals.
Body weight Blood glucose
(g) (mg/dL)
Before After Before After
treatment treatment treatment treatment
Group (0 day) (42 days) (0 day) (42 days)
Normal 185.16 ﾱ 3.31 208.66 ﾱ 4.22a 80.95 ﾱ 5.82 88.09 ﾱ 4.32b
Normal +
groundnut oil diet 176.50 ﾱ 2.25 198.16 ﾱ 3.18a,b 75.54 ﾱ 4.23 72.61 ﾱ 3.68a
Diabetic control 178.50 ﾱ 3.01 128.16 ﾱ 3.12c 251.78 ﾱ 9.78 322.61 ﾱ 9.49e
Diabetic + 173.50 ﾱ 3.14 159.66 ﾱ 3.55b 259.51 ﾱ 11.44 244.04 ﾱ 11.66d
groundnut oil diet
Diabetic + 181.50 ﾱ 4.37 201.50 ﾱ 5.39a,b 258.33 ﾱ 7.37 122.11 ﾱ 3.61c
glibenclamide
(600 ﾵg/kg b-wt)
Values are means ﾱ SD for six rats in each group. Values sharing a common superscript in
a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test
[DMRT]).
Ramesh et al.: Groundnut oil in streptozotocin-diabetic rats 11
fluoride (1:3) for the estimation of blood
glucose and in tubes with ethylenedi-
aminetetra acetic acid (EDTA) for the esti-
mation of HP, TBARS, GSH, vitamins C
and E, and lipid profile.Tissues such as liver
and kidney were collected and stored at 4 oC
for the estimations of enzymes.
Biochemical estimations
Blood glucose was estimated by the
method of Sasaki et al. [16]. Hb and HbA1c
were estimated by the methods of Drabkin
and Austin [17] and Sudhakar and Pattabi-
raman [18], respectively. The activities of
glucokinase, glucose-6-phosphatase and
fructose-1, 6-bisphosphatase were assayed
by the methods of Brandstrup et al. [19],
Koide and Oda [20], and Gancedo and
Gancedo [21], respectively. Plasma vitamin
C, vitamin E, GSH, TBARS, and HP were
estimated by the methods of Roe and
Kuether [22], Baker et al. [23], Ellman [24],
Nichans and Samuelson [25] and Jiang et al.
[26], respectively.TC [27], HDL-C [28] and
TG [29] were measured. LDL-C was calcu-
lated by Friedwald's formula [30].
Statistics
Results were expressed as means + SD,
for six rats in each group. Data were ana-
lyzed using one-way analysis of variance
(ANOVA), and group means were compared
with Duncan's Multiple RangeTest (DMRT)
[31] using SPSS-10.
RESULTS
Table 1 shows the effect of groundnut
oil on body weight and blood glucose in nor-
mal and STZ-diabetic rats. A significant
weight loss was observed in the diabetic
control group.The weight loss was minimal
in the oil-treated group, but significant im-
provement of weight was observed in the
group treated with standard drugs.Adrastic
increase in blood glucose level was found in
the diabetic control group. A small but sig-
nificant reduction in blood glucose level was
found in the diabetic animals fed groundnut
oil. The reduction was highly significant in
the drug-treated group.
Table 2 illustrates the effect of substitu-
tion of oil on Hb and HbA1c levels in normal
and STZ-diabetic rats. Hb level decreased
significantly while an increase in HbA1cwas
observed in diabetic rats when compared
with normal rats. Significant improvement
in Hb levels and a decrease in HbA1c were
observed in diabetic animals treated with
groundnut oil and glibenclamide, though itTable 2. Effect of groundnut oil in diet on Hb and HbA1c in normal and diabetic
animals.
Hb HbA1c
Group (g/dL) (mg/g of Hb)
Normal 10.92 ﾱ 0.37a 0.39 ﾱ 0.01b
Normal + groundnut oil diet 10.85 ﾱ 0.49a 0.34 ﾱ 0.02a
Diabetic control 6.12 ﾱ 0.15d 1.10 ﾱ 0.03e
Diabetic + groundnut oil diet 6.79 ﾱ 0.49c 0.99 ﾱ 0.02d
Diabetic + glibenclamide 9.73 ﾱ 0.49b 0.49 ﾱ 0.03c
(600 ﾵg/kg b-wt)
Values are means + SD for six rats in each group. Values sharing a common superscript in
a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test
[DMRT]).
Table 3. Effect of groundnut oil in diet on the activities of carbohydrate metabolic en-
zymes in liver and kidney of normal and diabetic animals.
Glucokinase Glucose-6- Fructose-1,6-
(Hexokinase D) phosphatase phosphatase
(Unit*/h/ (Unit**/min/ (Unit***/h/
mg protein mg/protein) mg/protein)
Group Liver Liver Kidney Liver Kidney
Normal 0.260 ﾱ 0.023a 0.165 ﾱ 0.011a 0.187 ﾱ 0.036a 0.412 ﾱ 0.027a 0.814 ﾱ 0.063a
Normal + 0.270 ﾱ 0.012a 0.156 ﾱ 0.022a 0.176 ﾱ 0.024a 0.395 ﾱ 0.028a 0.757 ﾱ 0.061a
groundnut oil
diet
Diabetic 0.079 ﾱ 0.009d 0.457 ﾱ 0.014d 0.272 ﾱ 0.016d 0.714 ﾱ 0.029d 1.169 ﾱ 0.042c
control
Diabetic + 0.116 ﾱ 0.009c 0.397 ﾱ 0.014c 0.236 ﾱ 0.016c 0.656 ﾱ 0.037c 1.016 ﾱ 0.151b
groundnut oil
diet
Diabetic + 0.216 ﾱ 0.014b 0.244 ﾱ 0.014b 0.203 ﾱ 0.018b 0.481 ﾱ 0.035b 0.802 ﾱ 0.037a
glibenclamide
(600 ﾵg/kg b-wt)
Values are means ﾱ SD for six rats in each group. Values sharing a common superscript in a column
are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]). * ﾵmoles of glucose
phosphorylated; ** ﾵmoles of inorganic phosphorous liberated; *** ﾵmoles of inorganic phosphorous
liberated.
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was more prominent in the drug-treated
group.
Table 3 shows the effect of groundnut
oil on carbohydrate metabolic enzymes in
tissues of normal and STZ-diabetic rats.The
hexokinase activity decreased, whereas the
activities of gluconeogenic enzymes such as
glucose-6-phosphatase and fructose-1, 6-
bisphosphatase increased in the liver and
kidney of diabetic rats when compared with
normal rats.Asignificant increase of hexok-
inase and reduction in glucose-6-
phosphatase and fructose-1, 6-bisphos-
phatase activities were observed in the
groups treated with groundnut oil and
glibenclamide when compared with diabetic
controls.
Table 4 illustrates the effect of ground-
nut oil on TBARS and HP in the plasma of
normal and STZ-diabetic rats. A significant
increase inTBARS and HPwas observed in
diabetic rats when compared with normal
rats.TBARS and HPdecreased significantly
in the plasma of diabetic rats fed withRamesh et al.: Groundnut oil in streptozotocin-diabetic rats 13
groundnut oil and treated with gliben-
clamide when compared with diabetic con-
trol rats. The decrease in the levels of
TBARS and HP was more remarkable in
glibenclamide-treated rats.
Table 5 shows the effect of groundnut
oil on antioxidants in the plasma of normal
and STZ-diabetic rats. A significant reduc-
tion of plasma vitamin C and GSH and in-
crease of vitamin E were observed in
diabetic rats when compared with control
rats. Significant increase in vitamin E and
GSH were found in diabetic rats fed with
groundnut oil when compared with diabetic
rats. The levels of vitamin C and GSH sig-
nificantly increased while vitamin E de-
creased in glibenclamide-treated rats when
compared with diabetic controls. An in-
crease in vitamin E also was observed in
normal rats fed with oil when compared
with the control group.
Table 6 shows the effect of groundnut
oil in the diet on plasma TC, VLDL-C,
LDL-C, HDL-C, TG, and TC/HDL-C ratio
in STZ-diabetic rats. In our study, diabetic
rats had elevated levels of TC, VLDL-C,
LDL-C, and TG and decreased levels of
HDL-C when compared with normal rats.
Diabetic rats fed with groundnut oil showed
a small but significant reduction in the levels
of TC, VLDL-C, LDL-C .and TG and ele-
vation in HDL-C level when compared with
diabetic controls, but diabetic animals
treated with glibenclamide showed better
improvement.
DISCUSSION
STZ is a commonly employed com-
pound for the induction of diabetes mellitus
in experimental rats [32]. It causes DNA
strand breaks in pancreatic islets, stimulates
Table 4. Effect of groundnut oil in diet on TBARS and HP in plasma of normal and
diabetic animals.
TBARS HP
Group (mmol/dl) (x 10-5 mmol/dl)
Normal 0.175 ﾱ 0.038a 9.81 ﾱ 0.98b
Normal + groundnut oil diet 0.162 ﾱ 0.030a 8.32 ﾱ 0.91a
Diabetic control 0.350 ﾱ 0.038c 24.15 ﾱ 1.07e
Diabetic + groundnut oil diet 0.262 ﾱ 0.041b 22.48 ﾱ 0.74d
Diabetic + glibenclamide 0.187 ﾱ 0.041a 11.06 ﾱ 0.59c
(600 ﾵg/kg b-wt)
Values are means ﾱ SD for six rats in each group. Values sharing a common superscript in
a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test
[DMRT]).
Table 5. Effect of groundnut oil in diet on vitamin C, vitamin E, and GSH in plasma of
normal and diabetic animals.
Vitamin C Vitamin E GSH
Group (mg/dl) (mg/dl) (mg/dl)
Normal 1.83 ﾱ 0.08a 6.32 ﾱ 0.24a 31.47 ﾱ 2.00b
Normal + groundnut oil diet 1.36 ﾱ 0.08b 7.42 ﾱ 0.24b 34.26 ﾱ 2.21a
Diabetic control 0.93 ﾱ 0.08c 14.66 ﾱ 0.22d 18.62 ﾱ 2.37d
Diabetic + groundnut oil diet 0.66 ﾱ 0.08d 18.92 ﾱ 0.27e 23.83 ﾱ 1.99c
Diabetic + glibenclamide 1.40 ﾱ 0.08b 9.57 ﾱ 0.27c 28.81 ﾱ 3.10b
(600 ﾵg/kg b-wt)
Values are means ﾱ SD for six rats in each group. Values sharing a common superscript in
a column are not significant with each other (p < 0.05, Duncan's Multiple Range Test
[DMRT]).nuclear poly (ADP-ribose) synthetase, and
thus depletes the intracellular NAD+ and
NADP+ levels, which inhibits proinsulin
synthesis and induces diabetes [33].The de-
crease in body weight in diabetic rats shows
that the loss or degradation of structural pro-
teins is due to diabetes, and the structural
proteins are known to contribute to the body
weight [34]. In diabetic rats fed with
groundnut oil, the weight loss was mini-
mized, which may be due to the reduction of
blood glucose. Groundnut oil-fed diabetic
rats showed a significant reduction in blood
glucose level. The reduction may be due to
the presence of MUFA. Rasmussen et al.
have reported reduction in peak plasma glu-
cose concentration with the consumption of
a MUFA-rich diet [7].An earlier report from
our laboratory shows that dietary substitu-
tion of sesame oil showed a better reduction
of blood glucose 322.61 + 9.49 to 222.02 +
8.27) than groundnut oil in STZ-diabetic rats
[35].
Insulin generally has an anabolic effect
on protein metabolism in that it stimulates
protein synthesis and retards protein degra-
dation[36].Previousreportshaveshownthat
protein synthesis is decreased in all tissues
due to decreased production of ATP and ab-
solute or relative deficiency of insulin [37],
which may be responsible for the decreased
level of Hb in diabetic rats. HbA1c comprises
3.4 percent to 5.8 percent of total Hb in nor-
malhumanredcells,butitisincreasedinpa-
tients with overt diabetes mellitus [38]. It
was found to increase in diabetic patients up
to 16 percent [39], and the level of HbA1c is
monitored as a reliable index of glycemic
control in diabetes [40]. Elevated levels of
HbA1c and reduced levels of Hb observed in
our study reveal that diabetic animals had
prior high blood glucose level. Groundnut
oil-fed diabetic rats showed an increase in
Hb level and decrease in HbA1c level, which
maybeduetothereductionof thebloodglu-
cose level.
In experimental diabetes, enzymes of
glucose metabolism are markedly altered.
Persistent hyperglycemia is a major contrib-
utor to such metabolic alterations that lead to
the pathogenesis of diabetic complications,
especially microvascular diseases [41]. One
of the key enzymes in the catabolism of glu-
cose is glucokinase, which phosphorylates
glucose to glucose-6-phosphate [42]. In our
study,theglucokinaseactivitywasdecreased
intheliverofdiabeticrats,whichmaybedue
to the deficiency of insulin. Groundnut oil-







and pyruvate carboxykinase [43]. Glucose-6-
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Table 6. Effect of groundnut oil in diet on TC, VLDL-C, LDL-C, HDL-C, and TG in normal
and diabetic animals.
TC VLDL-C LDL-C HDL-C TG
Group (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl)
Normal 82.00 ﾱ 1.74a 16.29 ﾱ 1.15a 24.71 ﾱ 2.13a 41.10 ﾱ 3.27d 81.45 ﾱ 2.00a
Normal + 84.20 ﾱ 2.20a 17.91 ﾱ 1.32b 31.44 ﾱ 3.14b 35.15 ﾱ 2.55c 90.38 ﾱ 2.41b
groundnut oil
diet
Diabetic control 131.20 ﾱ 1.09d 36.09 ﾱ 2.63d 67.13 ﾱ 5.24d 27.78 ﾱ 1.89a 180.45 ﾱ 4.85d
Diabetic + 116.33 ﾱ 1.50c 32.00 ﾱ 3.12c 54.68 ﾱ 4.33c 30.88 ﾱ 2.17b 160.95 ﾱ 3.74c
groundnut oil
diet
Diabetic + 91.66 ﾱ 1.75b 18.63 ﾱ 1.07b 33.59 ﾱ 2.98b 40.02 ﾱ 3.95d 93.15 ﾱ 2.29b
glibenclamide
(600 ﾵg/kg b-wt)
Values are means ﾱ SD for six rats in each group. Values sharing a common superscript in a column
are not significant with each other (p < 0.05, Duncan's Multiple Range Test [DMRT]).phosphataseisanimportantenzymeinhome-
ostasisofbloodglucoseasitcatalyzestheter-
minal step both in gluconeogenesis and
glycogenolysis [44]. Fructose-1, 6-bisphos-
phase is one of the key enzymes of gluco-
neogenic pathway. It is present in liver and
kidney but absent from heart, muscle, and
smoothmuscle.Inourstudy,theincreasedac-
tivitiesofglucose-6-phosphataseandfructose-
1, 6-bisphosphatase in liver and kidney of
diabetic rats may be due to insulin deficiency.
In oil-fed diabetic rats, the activities of these
two enzymes were significantly reduced,
which is responsible for the improved
glycemic control.
Diabetes mellitus has been reported to
generate reactive oxygen species (ROS).
ROS, such as free hydroxyl radicals (•OH)
and superoxide (O2•-), can cause lipid perox-
idation[45].Membranelipidperoxidationre-
sults in loss of PUFA, decreased membrane
fluidity, and loss of enzyme and receptor ac-
tivity. The products of lipid peroxidation are
capable of interacting with DNA and cause
oxidativedamage[46].Inourstudy,thelipid
peroxidationmarkerssuchasTBARSandHP
were significantly increased in the plasma of
STZ-diabeticratsasreportedearlier[47].The
levels of TBARS and HP were significantly
decreased in diabetic rats fed with oil, which
may be associated with decreased blood glu-
cose and the presence of vitamin E in the oil.
Oxidative stress occurs when there is an
imbalancebetweenfreeradicalreactionandthe
scavenging capacity of the antioxidative de-
fense mechanism of the organism [48]. The
nonenzymaticantioxidantssuchasGSH,vita-
min C, and vitamin E are interrelated by recy-
cling process [49]. Glutathione is the most
important non-protein compound-containing




showed a significant decrease in the level of
GSH, which may be due to increased utiliza-
tion. In oil-fed diabetic rats, a significant im-
provement in GSH was observed. This could
beduetothedecreasedutilizationof GSH.
Vitamin C is one of the most powerful
natural antioxidants [51]. It is capable of re-
generating α-tocopherol from the toco-
pheroxyl radical that is formed upon the in-
hibition of lipid peroxidation by vitamin E
[52]. Vitamin C has been reported to con-
tribute up to 24 percent of the total peroxyl
radical-trapping antioxidant activity (TRAP)
[53]. In our study, vitamin C was decreased
significantly in the plasma of diabetic rats as
reported earlier [54]. Groundnut oil-fed dia-
betic rats did not show any variation in vita-
min C levels. Among lipid soluble
antioxidants, α-tocopherol plays a central
role as it controls radical-induced lipopro-
tein lipid peroxidation [55]. In our study, vi-
tamin E level also was elevated significantly
in the plasma of diabetic rats as reported ear-
lier [56]. The increased level of α-toco-
pherol could be due to the increased release
from membrane damage by ROS. Ground-
nut oil-fed diabetic rats showed a significant
elevation of vitamin E in the plasma of dia-
betic rats. The increased level might be due
to the presence of vitamin E in the oil.
The levels of serum lipids are usually el-
evated in diabetes mellitus and such an eleva-
tion represents a risk factor for coronary heart
disease [57]. Diabetic rats fed with groundnut
oilshowedasmallbutsignificantreductionin
levels of TC, VLDL-C, LDL-C, and TG and





ing saturated fatty acids raise serum TC, TG,
and, in particular, LDL-C levels, while those
enriched in unsaturated fatty acids lower TC,
TG, and LDL-C [58, 59]. Diets high in mo-
nounsaturated fatty acids have been found to
berelativelyhypocholesterolemicorhypotria-
cylglycerolemic, respectively [60, 61].
In conclusion, our results show that
groundnut oil substitution in the diet influ-
ences blood glucose, lipid profile, lipid per-
oxidation, and antioxidants beneficially in
STZ-diabetic rats.
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